Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer.

Nature medicine - 1 Jul 2016

Dauch Daniel, Rudalska Ramona, Cossa Giacomo, Nault Jean-Charles, Kang Tae-Won, Wuestefeld Torsten, Hohmeyer Anja, Imbeaud Sandrine, Yevsa Tetyana, Hoenicke Lisa, Pantsar Tatu, Bozko Przemyslaw, Malek Nisar P, Longerich Thomas, Laufer Stefan, Poso Antti, Zucman-Rossi Jessica, Eilers Martin, Zender Lars

Abstract excerpt

MYC oncoproteins are involved in the genesis and maintenance of the majority of human tumors but are considered undruggable. By using a direct in vivo shRNA screen, we show that liver cancer cells that have mutations in the gene encoding the tumor suppressor protein p53 (Trp53 in mice and TP53 in humans) and that are driven by the oncoprotein NRAS become addicted to MYC stabilization via a mechanism mediated by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aurora Kinase A
Share to Azepines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Cycle Checkpoints

Share to Liver Neoplasms, Experimental

Share to Monomeric GTP-Binding Proteins

Share to Oncogene Protein p21(ras)

Share to Phenylurea Compounds

Share to Proto-Oncogene Proteins c-myc

Source

Identifiers

PMID: 27213815
DOI: 10.1038/nm.4107

Genes

AURKA
MYC
NRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer.PMID 27213815Read ↗

Aurora Kinase A: Integrating Insights into Cancer, Inflammation, and Infectious DiseasesSemantic proximity Read ↗

Biology of Aurora A kinase: Implications in cancer manifestation and therapySemantic proximity Read ↗

Aurora B kinase phosphorylates and instigates degradation of p53Semantic proximity Read ↗

Functional Significance of Aurora Kinases–p53 Protein Family Interactions in CancerSemantic proximity Read ↗

Design strategies, SAR, and mechanistic insight of Aurora kinase inhibitors in cancerSemantic proximity Read ↗

Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant stateSemantic proximity Read ↗

AURKB Enhances Chromosomal Remodeling of Telomeric Genes and Accelerates Tumorigenesis of Uveal MelanomaSemantic proximity Read ↗

A Focused Small-Molecule Screen Identifies PHA-680626 as an Amphosteric Inhibitor Disrupting the Interaction between Aurora-A and N-MycSemantic proximity Read ↗

Aurora-A promotes gefitinib resistance via a NF-κB signaling pathway in p53 knockdown lung cancer cells.Semantic proximity Read ↗

Phosphorylation of NuMA by Aurora-A kinase in PC-3 prostate cancer cells affects proliferation, survival, and interphase NuMA localization.Semantic proximity Read ↗

The N-terminal domain of the Aurora-A Phe-31 variant encodes an E3 ubiquitin ligase and mediates ubiquitination of IkappaBalpha.Semantic proximity Read ↗

Stabilization of N-Myc Is a Critical Function of Aurora A in Human NeuroblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.